Medical Cannabis, Autism, and the Transformation of Medicine
April 17, 2019
In 1987, during my freshman year at Lehigh University, our first English assignment was to write a letter to an elected official advocating for a controversial issue of our choosing. I decided to write my United States Congressman to express why I believed marijuana should be legalized. What was supposed to be a 3-4 page paper evolved into 11 pages, with each fact properly cited. I argued that people would be less likely to get marijuana laced with pesticides or other toxins; it could be taxed to generate much-needed revenues for the government; it would lower the crime rate and the overall cost to society. Besides being the most popular paper in the class, I received my first ‘A’ in college!
Over the next 20 years, I collaborated with parents to develop individualized treatment protocols using mostly natural products. The goal was to help children with autism, and subsequently, many other chronic medical conditions. Parents would ask me (or tell me) about tests and treatments of which they learned. I began attending and eventually lecturing at conferences sponsored by the Autism Research Institute. The ability to one day be able to legally order medical cannabis for children was never something I considered becoming a reality.
Incorporating Cannabis into Medical Treatment Plans
Fast forward to 2016, when Florida passed its first medical cannabis law, which allowed for the use of liquid and capsule form cannabidiol (CBD) for people with cancer, muscle spasms, and seizures. Since quite a few of my patients with autism had either seizures or tic-like movements that included muscle spasms, I became a cannabis certifying physician, so I could provide additional treatments for qualified patients. From there I began treating patients with CBD and quickly saw clinical improvements. Reduction of anxiety and/or irritability were soon being reported. Kids were sleeping better. Some children stopped stimming. Tics improved. We were definitely on to something.
But not all children improved, and in 2017, “regular” cannabis, containing 9-delta Tetrahydrocannabinol (THC) became available. THC is what causes the euphoric/psychoactive effect typically associated with marijuana use.
Improvements to Medical Cannabis Laws
Under the new law, licensed physicians who become certified by the State are able to authorize qualified patients to receive medical cannabis; this includes children, as long as a second doctor agrees. Certified doctors can also now authorize cannabis use for patients suffering from debilitating medical conditions similar to those listed in the statute, such as PTSD, Parkinson’s, Crohn’s, etc.
With the new law in place, I quickly concluded that, similar to patients with PTSD, many people with autism suffer similarly debilitating anxiety, panic attacks, insomnia, and aggressive behaviors. Others had difficulty speaking, as is common in people with Parkinson’s disease, or had chronic abdominal issues similar to those associated with Crohn’s disease. With fully-informed parental consent, the parents/caregivers are allowed to purchase, possess, and administer medical cannabis to the children.
To be clear, very minimal research has been conducted on the use of cannabis in children. There are concerns about memory and cognitive function, especially when a developing brain is exposed to THC. It is critical that parents take into account the potential benefits and risks, as well as the alternatives when deciding on any treatment for a child. Doing nothing is one alternative, but for most families, that is not an option. Pharmacological intervention is often considered. However, many families tell me that they are considering medical cannabis because other medications either didn’t work well enough or brought unacceptable side effects. Some also say that they are uncomfortable placing their child on specific prescription medications because of the reported side effects.
Pediatric Medical Cannabis
As one of the first board-certified pediatricians in the State of Florida to specialize in pediatric cannabis therapy, I am relatively sure I have certified more children for medical cannabis treatment than any other doctor in Florida. Every day at my clinic I hear about another child whose life is improved and whose entire family has benefited because of medical cannabis.
For out-of-state families, I provide educational consultations, where I consult on how to put together a protocol to optimize the use of medical cannabis. When requested, I also help families shop online if they tell me the dispensaries/products that are available to them.
As I look back over this 30-year journey, I am amazed how far we have come. I look forward to hearing many more amazing and inspiring stories about people with autism and other qualifying conditions whose lives have been transformed with medical cannabis.
Dr. David Berger (“Dr. David”), a Board Certified Pediatrician with over 20 years of experience as a clinician, has developed a national reputation in wholistic pediatric primary care. Dr. David is considered Tampa Bay area’s leading authority on medical cannabis for adults and children, and is one of the nation’s most experienced pediatricians using medical cannabis to help facilitate the treatment of children with chronic conditions.
Dr. David graduated from The Medical College of Pennsylvania in 1994 and completed his pediatric residency at the University of South Florida/Tampa General Hospital where he first began utilizing wholistic therapies. Dr. David has been in private practice since 1997 and in 2005 opened Wholistic Pediatrics & Family Care, his medical practice in Tampa, Florida. In 2010, Dr. David was appointed Assistant Professor at the University of South Florida College of Nursing. In 2016, he launched Wholistic ReLeaf to help qualified patients become certified to use medical cannabis.